Rising Innovation in Rare Diseases: PNH Market Set for Robust Growth Through 2034
The global Paroxysmal Nocturnal Hemoglobinuria (PNH) market is entering a transformative era marked by innovation, expanding patient access, and sustained investment in rare disease therapeutics. Valued at US$ 3.8 Bn in 2023, the market is projected to grow at a CAGR of 10.8% from 2024 through 2034, ultimately reaching US$ 11.7 Bn by the end of the forecast period. This impressive growth is...
0 Yorumlar 0 hisse senetleri 72 Views 0 önizleme
Gojjochat https://gojjochat.com